Journal of Biomedical Science Submission Guide: What to Prepare Before You Submit
Science's submission process, first-decision timing, and the editorial checks that matter before peer review begins.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
Readiness scan
Before you submit to Science, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
Key numbers before you submit to Science
Acceptance rate, editorial speed, and cost context — the metrics that shape whether and how you submit.
What acceptance rate actually means here
- Science accepts roughly <7% of submissions — but desk rejection runs higher.
- Scope misfit and framing problems drive most early rejections, not weak methodology.
- Papers that reach peer review face a different bar: novelty, rigor, and fit with the journal's editorial identity.
What to check before you upload
- Scope fit — does your paper address the exact problem this journal publishes on?
- Desk decisions are fast; scope problems surface within days.
- Cover letter framing — editors use it to judge fit before reading the manuscript.
How to approach Journal of Biomedical Science
Use the submission guide like a working checklist. The goal is to make fit, package completeness, and cover-letter framing obvious before you open the portal.
Stage | What to check |
|---|---|
1. Scope | Confirm the manuscript reads as molecular or mechanistic biomedical work |
2. Package | Finalize supporting information, authorship, and disclosure details |
3. Cover letter | Submit only when the first read makes the biomedical consequence obvious |
Quick answer: This Journal of Biomedical Science submission guide starts with the central fit question. The official journal scope is broad, but not loose. It emphasizes fundamental and molecular aspects of basic medical sciences, especially molecular studies of biomedical problems and mechanisms. That means a paper can be scientifically sound and still be mistargeted if it reads too local, too descriptive, or too weakly connected to a broader biomedical question.
From our manuscript review practice
Of manuscripts we review for broad biomedical journals, the most common early failure is a paper that is competent inside one niche but does not yet read like a molecular biomedical advance for a wider audience.
Journal of Biomedical Science: Key submission facts
Requirement | Details |
|---|---|
2024 JIF | 12.1 |
Quartile | Q1 |
Publisher | Springer Nature |
Publishing model | Open access |
Submission route | Springer Nature online submission system |
APC | No fee to publish; APC covered by Taiwan's National Science and Technology Council |
Scope emphasis | Fundamental and molecular aspects of basic medical sciences |
What Journal of Biomedical Science is actually screening for
This journal is broad across biomedical domains, but the strongest submissions still share a recognizable profile.
Editors are usually asking:
- does the manuscript make a real contribution to a biomedical problem rather than a narrow technical one
- is the molecular or mechanistic content strong enough for the claim
- can readers outside the immediate subfield understand why the result matters
- does the paper behave like a broad biomedical article rather than a specialist report looking for a higher-impact home
That is why the journal can accept work from many fields while still rejecting a lot of respectable specialty science.
The papers that travel best here usually make one legible promise early: this study does not just report a result, it improves how biomedical readers understand a mechanism, disease process, or experimental system that matters outside one narrow lane.
Before you submit
Pressure-test these points before upload:
- the abstract states the biomedical problem and the main mechanistic or molecular advance directly
- the paper travels beyond one narrow laboratory technique or disease micro-niche
- the medical or biological consequence is visible in the data, not just argued in the discussion
- the manuscript, supporting information, authorship, and licensing details are already stable
- the submission is being made by an author, not assembled through a third-party process
If the manuscript would only feel compelling to one tightly bounded subspecialty readership, the fit is weaker than authors often think.
What the official materials make explicit
The live submission guidance is operationally straightforward and unusually clear about journal identity.
Official signal | Why it matters |
|---|---|
The scope covers fundamental and molecular aspects of basic medical sciences | The paper should feel mechanistic or conceptually biomedical, not only descriptive |
Topics span pathology, biochemistry, genetics, immunology, microbiology, neuroscience, pharmacology, and physiology | Interdisciplinary breadth is welcome, but only when the core biomedical story stays strong |
The journal is open access with APC support covered by NSTC | Route and cost friction are lower, so editorial fit becomes even more important |
Authors are directed to prepare the manuscript, supporting information, and editorial-policy disclosures before submission | The first-submission package should already be complete |
A manuscript can only be submitted by an author of the manuscript | Final authorship and submission ownership should be settled before upload |
The practical implication is that Journal of Biomedical Science is easier to submit to than to place well. The gate is not portal complexity. It is level and scope.
That matters especially for interdisciplinary work. The journal welcomes wide-ranging biomedical topics, but the manuscript still has to read cleanly enough that readers from adjacent areas can understand why it deserves attention.
This is where many borderline submissions quietly fail. The authors know why the study matters inside their own lane, but the manuscript has not yet been written so that a broader biomedical editor can see the mechanistic payoff, the medical relevance, and the readership case in one fast, confident, editorial first pass. That readability matters.
Common failure patterns at this journal
1. The manuscript is too narrow for the readership
A solid study can still be too specialized if the readership case only works for one subdiscipline.
2. The molecular mechanism is thinner than the headline
Because the journal explicitly emphasizes molecular studies and mechanisms, papers that rely heavily on description or association often feel one step short.
3. The biomedical consequence is asserted rather than carried
We often see manuscripts that use disease framing in the introduction and discussion, but the figures themselves do not yet support a strong biomedical takeaway.
Before submission, a broad-biomedical readiness check can tell you whether the weakness is mechanism, readership, or consequence.
Readiness check
Run the scan while Science's requirements are in front of you.
See how this manuscript scores against Science's requirements before you submit.
Cover letter and package checklist
Before you upload, make sure the package already answers these questions:
- what biomedical problem does this paper advance
- what is the molecular or mechanistic contribution
- why does the result matter beyond the exact specialty that produced it
- are the supporting files, disclosures, and authorship details final
- does the abstract show the consequence early enough for a fast editorial read
At this level, the cover letter should explain the biomedical importance cleanly, not just restate the methods.
In our pre-submission review work with manuscripts targeting Journal of Biomedical Science
In our pre-submission review work with manuscripts targeting Journal of Biomedical Science, three patterns show up repeatedly before peer review starts.
- The study is technically sound but too local. It may be publishable, but the paper is written for insiders rather than for a broader biomedical audience.
- The mechanism is still too light for the claim. We often see strong phenotypes, correlations, or pathway associations that need one more mechanistic step.
- The paper says "biomedical" more clearly than it shows it. The disease or physiology relevance is present in framing, but not yet load-bearing in the evidence.
A pre-submission biomedical fit check is useful here because many avoidable misses are journal-level and positioning errors, not irreparable science failures.
Journal of Biomedical Science versus nearby alternatives
Journal | Best fit | Think twice if |
|---|---|---|
Journal of Biomedical Science | Broad molecular or mechanistic biomedical work with interdisciplinary reach | The paper mainly serves one narrow specialty audience |
JCI Insight | Disease-focused work with a stronger physician-scientist readership case | The human or translational angle is thin |
Genome Biology | Omics or computational biology work with broader platform or systems consequence | The manuscript is mainly conventional basic biomedical science |
Strong specialty journal | Deep field-specific work for an expert niche | The paper genuinely travels across biomedical areas |
The right call depends on whether the manuscript's real strength is breadth or specialization.
Submit If
- the manuscript advances a real biomedical question
- the molecular or mechanistic contribution is visible in the data
- the paper can travel beyond one narrow subfield
- the abstract explains the consequence quickly
- the package is complete before upload
Think Twice If
- the study is mainly descriptive without enough mechanism
- the biomedical relevance appears mostly in framing language
- the readership case depends on a very specialized audience
- the title, abstract, and main figures still need repositioning to make the importance clear
Before upload, run a broad-biomedical first-read check to see whether the paper belongs here.
Frequently asked questions
Journal of Biomedical Science uses the Springer Nature submission workflow. Before upload, make sure the manuscript already reads as a strong molecular or fundamental biomedical paper rather than a narrow specialty report.
The official scope emphasizes fundamental and molecular aspects of basic medical sciences, with particular focus on molecular studies of biomedical problems and mechanisms. Editors are usually screening for clear biomedical consequence and more than routine descriptive science.
The official journal guidance says there is no fee to publish because the article processing charge is covered by Taiwan's National Science and Technology Council. Authors should still confirm any current funding or licensing details before submission.
Common reasons include a manuscript that is too narrow for the journal's interdisciplinary biomedical readership, a paper that is technically sound but weak on molecular mechanism, and a study whose medical relevance is asserted more than demonstrated.
Sources
Final step
Submitting to Science?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Same journal, next question
Supporting reads
Conversion step
Submitting to Science?
Anthropic Privacy Partner. Zero-retention manuscript processing.